Check out our most popular compounded medications! Get Started
This is a semisolid formulation of Polymyxin B 6,320 U/ml and Bacitracin 500 U/ml topical gel. It is dispensed through a pump mechanism for easy and precise application. The gel-like consistency allows for targeted treatment or absorption of the active ingredients. It is used to treat conditions such as Impetigo, Cellulitis, Folliculitis, Erysipelas, and Furunculosis.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present a unique topical gel formulation of Polymyxin B 6,320 U/ml/Bacitracin 500 U/ml. This antibiotic combination is a potent remedy for various skin infections, including impetigo, folliculitis, and furunculosis.
The Polymyxin B component of the formulation is a polypeptide antibiotic that functions by disrupting the bacterial cell membrane, leading to cell death. On the other hand, the Bacitracin component is a polypeptide antibiotic that inhibits the synthesis of bacterial cell wall components, also leading to cell death.
This topical gel formulation is a semisolid preparation dispensed through a pump mechanism, facilitating easy and precise application on the skin for targeted treatment or absorption of active ingredients. Its gel-like consistency ensures that it is well tolerated by patients and allows for targeted treatment. It is available in various sizes and can be used for both short-term and long-term treatment of skin infections.
If you have any queries about this formulation or its application in treating skin infections, please do not hesitate to contact us at Bayview Pharmacy. Our team of experienced compounding pharmacists is always ready to assist you in finding the most suitable treatment option for your patients.
Polymyxin B 6,320 U/ml/Bacitracin 500 U/ml Topical Gel is a semisolid formulation that is dispensed through a pump mechanism. This design allows for easy and precise application on the skin, ensuring targeted treatment or absorption of the active ingredients. The gel-like consistency of the formulation enhances its adherence to the skin, promoting optimal therapeutic effect.
While no clinically significant drug-drug interactions have been reported with the use of this topical gel, it is crucial to avoid using it in conjunction with other topical antibiotics. This precaution is necessary to prevent the potential risk of developing antibiotic resistance. It is also important to avoid contact with the eyes as this may cause irritation. Similarly, application on open wounds or broken skin should be avoided as it may increase the risk of infection.
Patients are advised to monitor their response to the treatment closely. In case of any adverse reactions, such as skin irritation, redness, or swelling, it is recommended to discontinue use immediately and consult with a healthcare provider. It is always important to use this medication as directed by a healthcare professional to ensure its safety and efficacy.
If you have any questions or concerns about the use of Polymyxin B 6,320 U/ml/Bacitracin 500 U/ml Topical Gel, do not hesitate to seek advice from a healthcare provider. They can provide you with the most accurate and relevant information based on your specific health condition and needs.
Polymyxin B 6,320 U/ml/Bacitracin 500 U/ml Topical Gel is a compounded formulation that combines two potent antibiotics, polymyxin B and bacitracin, designed to effectively treat bacterial skin infections. Polymyxin B operates by disrupting the bacterial cell wall, while bacitracin inhibits bacterial protein synthesis. The synergistic action of these two antibiotics provides a powerful treatment against bacterial skin infections.
This topical gel is dispensed through a pump mechanism, which facilitates easy and precise application on the skin. The gel-like consistency allows for targeted treatment and efficient absorption of the active ingredients. Once applied, the gel is absorbed through the skin and enters the bloodstream, reaching the site of infection. The gel formulation also ensures that the antibiotics remain in contact with the skin for an extended period, enhancing the effectiveness of the treatment.
Polymyxin B 6,320 U/ml/Bacitracin 500 U/ml Topical Gel is indicated for the treatment of bacterial skin infections such as impetigo, folliculitis, and furunculosis. The gel should be applied to the affected area two to three times a day, or as directed by a healthcare provider.
It is crucial to understand that Polymyxin B 6,320 U/ml/Bacitracin 500 U/ml Topical Gel is not designed to treat viral or fungal infections. If you have any questions or concerns about the use of this formulation, it is recommended to consult with a healthcare provider.
This compounded formulation of Polymyxin B 6,320 U/ml/Bacitracin 500 U/ml Topical Gel is a semisolid preparation that is dispensed through a pump mechanism. This design allows for easy and precise application on the skin, ensuring targeted treatment or absorption of the active ingredients in a gel-like consistency. It is primarily used to treat superficial skin infections caused by susceptible bacteria. These may include conditions such as superficial pyoderma, infected dermatitis, and infected eczema.
Furthermore, this formulation can also be used to treat infected wounds, which may be a result of trauma, surgery, or burns.
If you have any questions or concerns about the use of this formulation, please do not hesitate to reach out for further clarification. It is always important to use such formulations under the guidance of a healthcare professional to ensure safety and effectiveness.
This is a semisolid formulation that contains Polymyxin B and Bacitracin as active ingredients. It is dispensed through a pump mechanism for easy and precise application on the skin.
The gel has a semisolid, gel-like consistency that allows for targeted treatment or absorption of the active ingredients.
The gel is dispensed through a pump mechanism, which facilitates easy and precise application on the skin.
The active ingredients in this topical gel are Polymyxin B and Bacitracin.
The pump mechanism allows for easy and precise application of the gel on the skin, ensuring that the right amount of medication is applied each time.
It's important to use this medication only as directed by a healthcare professional. It is typically used for specific skin conditions that respond to the active ingredients Polymyxin B and Bacitracin.
Store this medication at room temperature, away from heat and direct light. Do not freeze. Keep out of the reach of children.
If you miss a dose of this medication, apply it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
If you suspect an overdose, seek medical attention immediately. Symptoms of an overdose may include severe skin irritation or rash.
Some people may experience side effects such as skin irritation, rash, or itching. If these symptoms persist or worsen, contact your healthcare provider immediately.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
